Hatch BioFund Announces New Partnership with Brandywine Realty Trust <<more here>>

About Wenhui Li, PhD

 After earning a Ph.D. in 2001 from the Peking Union Medical College and the Chinese Academy of Medical Sciences, Dr. Li worked as a postdoctoral fellow and then as an instructor at Harvard Medical School, Boston. In 2007, he joined NIBS Beijing, where he has focused on viral infection of hepatitis B and hepatitis D. Dr. Li’s research led to the discovery that a multiple transmembrane bile acids transporter (NTCP, sodium taurocholate co-transporting polypeptide), predominantly expressed in liver, is a functional receptor for HBV and HDV. Dr. Li is now an investigator at NIBS and a professor at the Tsinghua Institute of Multidisciplinary Biomedical Research.

Read more about him here

Read our news release about Dr. Li's selection for the Blumberg Prize here.

To return to the Distinguished Speaker Seminar page, click here